+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pravastatin, simvastatin, and atorvastatin appear equally effective for preventing cardiovascular events



Pravastatin, simvastatin, and atorvastatin appear equally effective for preventing cardiovascular events



Evidence-Based Cardiovascular Medicine 10(2): 135-137




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049971842

Download citation: RISBibTeXText

PMID: 16753534

DOI: 10.1016/j.ebcm.2006.04.048


Related references

Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats. World Journal of Diabetes 6(10): 1168-1178, 2015

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events. Plos One 9(3): E90325, 2016

Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Yearbook of Endocrinology 2007: 118-119, 2007

Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. American Heart Journal 151(2): 273-281, 2006

Rosuvastatin is Cost-Effective in Treating Patients to Low-Density Lipoprotein-Cholesterol Goals Compared with Atorvastatin, Pravastatin and Simvastatin: Analysis of the Stellar Trial. European Journal of Cardiovascular Prevention & Rehabilitation 12(1): 18-28, 2005

Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial. European Journal of Cardiovascular Prevention and Rehabilitation 12(1): 18-28, 2005

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events. Clinicoeconomics and Outcomes Research 4: 1-11, 2012

Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program. Fortschritte der Medizin 114(8): 91-98, 1996

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 92(9): 2419-2425, 1995

Comparison of atorvastatin, a new Hmg-CoA reductase inhibitor, with pravastatin and simvastatin. Atherosclerosis 109(1-2): 314, 1994

Effect of Efavirenz on the Pharmacokinetics of Simvastatin, Atorvastatin, and Pravastatin. Jaids Journal of Acquired Immune Deficiency Syndromes 39(3): 307-312, 2005

Analysis of cost-effectiveness of simvastatin versus atorvastatin in the secondary prevention of cardiovascular events within the Brazilian public healthcare system. Value in Health 14(5 Suppl 1): S29-S32, 2011

Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia. Wiener Klinische Wochenschrift 114(23-24): 999-1003, 2003

Effects of pravastatin, atorvastatin and simvastatin on myocardial stunning in pigs. FASEB Journal 14(4): A423, March 15, 2000

Grapefruit juice increases serum simvastatin and atorvastatin but not pravastatin. Clinical Pharmacology & Therapeutics 65(2): 180, 1999